Creativity in Pediatric Clinical Pharmacology: Study Design and Oral Dosage Forms.
作者信息
Zajicek Anne
机构信息
Program Director, Office of Clinical Research Education and Collaboration Outreach, Office of Intramural Research, Office of the Director, National Institutes of Health, Bethesda, MD.
出版信息
J Pediatr Pharmacol Ther. 2024 Dec;29(6):564-569. doi: 10.5863/1551-6776-29.6.564. Epub 2024 Dec 9.
Abstract
摘要
相似文献
1
Creativity in Pediatric Clinical Pharmacology: Study Design and Oral Dosage Forms.儿科临床药理学中的创新：研究设计与口服剂型
J Pediatr Pharmacol Ther. 2024 Dec;29(6):564-569. doi: 10.5863/1551-6776-29.6.564. Epub 2024 Dec 9.
2
Formulation Challenges and Strategies to Develop Pediatric Dosage Forms.开发儿科剂型的配方挑战与策略
Children (Basel). 2022 Apr 1;9(4):488. doi: 10.3390/children9040488.
3
Pediatric drug development: formulation considerations.儿科药物研发：剂型考量
Drug Dev Ind Pharm. 2014 Oct;40(10):1283-99. doi: 10.3109/03639045.2013.850713. Epub 2014 Jan 31.
4
Neonatal and pediatric oral drug delivery: Hopes and hurdles.新生儿和儿科口腔药物传递：希望与障碍。
Int J Pharm. 2021 Mar 15;597:120296. doi: 10.1016/j.ijpharm.2021.120296. Epub 2021 Jan 29.
5
Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation.药物标签变更与儿科血液学/肿瘤学处方：衡量美国立法的影响。
Clin Trials. 2021 Dec;18(6):732-740. doi: 10.1177/17407745211030683. Epub 2021 Jul 16.
6
Potential pharmacokinetic interaction between orally administered drug and osmotically active excipients in pediatric polypharmacy.口服药物与儿科多药治疗中渗透活性赋形剂的潜在药代动力学相互作用。
Eur J Pharm Sci. 2021 Oct 1;165:105934. doi: 10.1016/j.ejps.2021.105934. Epub 2021 Jul 10.
7
Review of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act: What can the obstetric community learn from the pediatric experience?《儿童最佳药品法案》及《儿科研究公平法案》综述：产科界能从儿科经验中学到什么？
Semin Perinatol. 2015 Nov;39(7):530-1. doi: 10.1053/j.semperi.2015.08.006. Epub 2015 Oct 9.
8
A Systematic Literature Review on the Assessment of Palatability and Swallowability in the Development of Oral Dosage Forms for Pediatric Patients.一篇关于儿科患者口服剂型开发中口感和吞咽性评估的系统文献综述。
Ther Innov Regul Sci. 2013 Sep;47(5):533-541. doi: 10.1177/2168479013500288.
9
Age-Appropriate Pediatric Dosage Forms in Japan: Insights into End-User Perceptions From an Observational Cross-Sectional Survey Assessing the Acceptability of Oral Formulation.日本适合儿童年龄的剂型：通过一项评估口服制剂可接受性的观察性横断面调查洞察终端用户的看法。
Ther Innov Regul Sci. 2019 Jul;53(4):455-471. doi: 10.1177/2168479018791133. Epub 2018 Aug 29.
10
Pharmacometric Modeling and Simulation Is Essential to Pediatric Clinical Pharmacology.药物代谢动力学建模与模拟对儿科临床药理学至关重要。
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S73-S85. doi: 10.1002/jcph.1316.
本文引用的文献
1
Inkjet Printing of Pharmaceuticals.喷墨打印制药。
Adv Mater. 2024 Mar;36(11):e2309164. doi: 10.1002/adma.202309164. Epub 2023 Dec 12.
2
Pediatric Efficacy Extrapolation in Drug Development Submitted to the US Food and Drug Administration 2015-2020.2015-2020 年向美国食品和药物管理局提交的药物开发中的儿科疗效外推。
J Clin Pharmacol. 2023 Mar;63(3):307-313. doi: 10.1002/jcph.2160. Epub 2022 Oct 19.
3
Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease.阿昔洛韦治疗新生儿单纯疱疹病毒病的暴露-安全关系。
Early Hum Dev. 2022 Jul;170:105616. doi: 10.1016/j.earlhumdev.2022.105616. Epub 2022 Jun 22.
4
Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship.氨苄西林治疗早产儿早发性败血症的剂量：基于暴露的疗效、安全性和管理。
J Perinatol. 2022 Jul;42(7):959-964. doi: 10.1038/s41372-022-01344-2. Epub 2022 Feb 24.
5
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling.基于生理药代动力学建模的肥胖儿童虚拟人群的开发与评估
Clin Pharmacokinet. 2022 Feb;61(2):307-320. doi: 10.1007/s40262-021-01072-4. Epub 2021 Oct 7.
6
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants.美罗培南在早产儿和足月儿体内的生理药代动力学模型研究。
Clin Pharmacokinet. 2021 Dec;60(12):1591-1604. doi: 10.1007/s40262-021-01046-6. Epub 2021 Jun 22.
7
Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients.使用 3D 打印技术自动化制备异亮氨酸制剂治疗 MSUD：首个在患者中进行的单中心、前瞻性、交叉研究。
Int J Pharm. 2019 Aug 15;567:118497. doi: 10.1016/j.ijpharm.2019.118497. Epub 2019 Jul 4.
8
Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.新生儿氨苄西林血浆和干血斑药代动力学的比较分析
Ther Drug Monit. 2018 Feb;40(1):103-108. doi: 10.1097/FTD.0000000000000466.
9
Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections.高剂量阿昔洛韦用于疑似和确诊新生儿单纯疱疹病毒感染婴儿的安全性
Pediatr Infect Dis J. 2017 Apr;36(4):369-373. doi: 10.1097/INF.0000000000001451.
10
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.电子健康记录与药代动力学建模以评估新生儿氨苄西林暴露与癫痫发作风险之间的关系。
J Pediatr. 2016 Nov;178:125-129.e1. doi: 10.1016/j.jpeds.2016.07.011. Epub 2016 Aug 10.
Zotero 插件